Literature DB >> 34772709

Anna N Wilkinson1, Stephen Lam2.   

Abstract

Entities:  

Year:  2021        PMID: 34772709      PMCID: PMC8589131          DOI: 10.46747/cfp.6711823

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  32 in total

1.  Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring.

Authors:  Joshua D Mitchell; Nicole Fergestrom; Brian F Gage; Robert Paisley; Patrick Moon; Eric Novak; Michael Cheezum; Leslee J Shaw; Todd C Villines
Journal:  J Am Coll Cardiol       Date:  2018-12-25       Impact factor: 24.094

Review 2.  Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.

Authors:  Mark H Ebell; Michelle Bentivegna; Cassie Hulme
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

3.  Organized Lung Cancer Screening Pilot: Informing a Province-Wide Program in Ontario, Canada.

Authors:  Gail E Darling; Martin C Tammemägi; Heidi Schmidt; Daniel N Buchanan; Yvonne Leung; Caitlin McGarry; Linda Rabeneck
Journal:  Ann Thorac Surg       Date:  2020-10-08       Impact factor: 4.330

4.  The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.

Authors:  Sonya Cressman; Stuart J Peacock; Martin C Tammemägi; William K Evans; Natasha B Leighl; John R Goffin; Alain Tremblay; Geoffrey Liu; Daria Manos; Paul MacEachern; Rick Bhatia; Serge Puksa; Garth Nicholas; Annette McWilliams; John R Mayo; John Yee; John C English; Reka Pataky; Emily McPherson; Sukhinder Atkar-Khattra; Michael R Johnston; Heidi Schmidt; Frances A Shepherd; Kam Soghrati; Kayvan Amjadi; Paul Burrowes; Christian Couture; Harmanjatinder S Sekhon; Kazuhiro Yasufuku; Glenwood Goss; Diana N Ionescu; David M Hwang; Simon Martel; Don D Sin; Wan C Tan; Stefan Urbanski; Zhaolin Xu; Ming-Sound Tsao; Stephen Lam
Journal:  J Thorac Oncol       Date:  2017-05-10       Impact factor: 15.609

5.  Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Authors:  Nikolaus Becker; Erna Motsch; Anke Trotter; Claus P Heussel; Hendrik Dienemann; Philipp A Schnabel; Hans-Ulrich Kauczor; Sandra González Maldonado; Anthony B Miller; Rudolf Kaaks; Stefan Delorme
Journal:  Int J Cancer       Date:  2019-06-20       Impact factor: 7.396

6.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

7.  Cancer incidence among First Nations adults in Canada: follow-up of the 1991 Census Mortality Cohort (1992-2009).

Authors:  Maegan V Mazereeuw; Diana R Withrow; E Diane Nishri; Michael Tjepkema; Loraine D Marrett
Journal:  Can J Public Health       Date:  2018-06-28

8.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

9.  Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.

Authors:  Joan E Walter; Marjolein A Heuvelmans; Pim A de Jong; Rozemarijn Vliegenthart; Peter M A van Ooijen; Robin B Peters; Kevin Ten Haaf; Uraujh Yousaf-Khan; Carlijn M van der Aalst; Geertruida H de Bock; Willem Mali; Harry J M Groen; Harry J de Koning; Matthijs Oudkerk
Journal:  Lancet Oncol       Date:  2016-06-06       Impact factor: 41.316

10.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.